US FDA declines to approve GSK drugs division’s long acting HIV injection
ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » GlaxoSmithKline
Browsing Tag
GlaxoSmithKline
Healthcare industry sets 52 deals worth US$9.5 bn in Oct’19
The industry also reported 85 venture capital (VC) deals worth US$1.7 billion in October 2019, compared to the last 12-month…
AstraZeneca lupus drug shows promise after set-back last year
The drug had failed to meet its main goal in the final stage of one of the two clinical trials under the TULIP programme last year…
GSK builds oncology pipeline as drug shown to help myeloma patients
Two doses of belantamab mafodotin helped subdue disease in adults who received three prior treatments for multiple myeloma
GSK’s Dovato suppresses AIDS virus at same levels of three-drug regimen
The positive results further bolster GSK’s efforts to challenge US drugmaker Gilead, which currently leads the HIV treatment…
GlaxoSmithKline posts loss as it integrates new businesses
Drug makers like GSK have been trying to focus on strengths amid competition from generic drug makers
British-based drug maker…
Glenmark in agreement with Celon Pharma
Glenmark obtains semi-exclusive marketing and distribution rights for the product across 15 European countries, including Great…
Novartis acquires all remaining rights to GSK’s Ofatumumab
To develop treatments for MS and other autoimmune indications
MSF takes to social media to pressurise GSK, Pfizer to cut price of flu shot
Urges public to #AskPharma how developing countries can get ‘A FAIR SHOT’ when vaccine prices are being kept secret
GSK agrees UK deal for meningitis shot after Novartis stand-off
Britain will become the first country in the world to have a nationwide vaccination programme for the potentially deadly childhood…